Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3520
0.00 (0.00%)
May 11, 2026, 10:01 AM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 104.31 million as of May 8, 2026. Its market cap has increased by 230.74% in one year.
Market Cap
104.31M
Enterprise Value
97.44M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 104.31M, an increase of 145.39%. That is a compound annual growth rate of 19.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 104.31M | -9.84% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 144.59M |
| Nyrada | 137.17M |
| Dimerix | 129.09M |
| Alterity Therapeutics | 119.63M |
| Paradigm Biopharmaceuticals | 97.21M |
| Arovella Therapeutics | 91.87M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |